Interferons (IFNs) are cytokines that have documented efficacy in the treatment of hairy cell leukemia, and show promising results in the treatment of renal cell carcinoma, chronic myelocytic leukemia, hepatitis and acquired immune deficiency syndrome. The goal of the proposed research program is to define the molecular basis of the antiproliferative action of IFNs, focussing on characterization of the IFN alpha receptor; the antagonism of IFN alpha with growth factors at the level of signal transduction pathways; and IFN alpha-induced down-regulation of growth factor receptor expression. Studies of the basis for the antiproliferative action of IFN are critically aided by comparative analysis of the effects of IFN on sensitive and resistant Daudi and renal carcinoma cell lines all of which express IFN receptors. Such cell lines permit critical experiments to identify specific mechanisms underlying the inhibitory action of IFN alpha on cell proliferation. Using such cell lines, we will define the roles of IFN alpha-induced receptor dimerization, the high and low affinity binding components, and the glycosylated portion of the IFN alpha receptor in IFN-induced expression of IFN-stimulated genes (ISGs) and the induction of antiproliferative and antiviral activities. Based on our recent findings that IFN alpha stimulates GTP binding to membranes and depresses arachidonic acid (AA) release in IFN- sensitive but not in resistant cells, we hypothesize that these may be early and perhaps obligatory steps in the antiproliferative action of IFN alpha. The role of GTP-binding proteins in IFN action will be investigated in the activation of ISGs and the antiproliferative action of IFN. We propose that IFN blocks signal transduction pathways activated by relevant growth factors (EGF, PDGF, insulin, etc.). We will directly examine the effects of IFN on arachidonic acid (AA) release, protein kinase C activity, and membrane GTPase activity in the presence and absence of added growth factors. Some important effects of IFN on cell function become manifest only after a period of several hours. Based on our findings that down-regulation of growth factor receptors by IFN alpha treatment attenuates the ability of cells to respond to such factors, we will determine whether IFN modulates growth factor receptor expression at both transcriptional and post- transcriptional levels. We will define post-transcriptional effects of IFN alpha by measuring the phosphorylation and recycling of insulin, transferrin and EGF receptors, and the stability of the mRNA for these receptors. We plan to define the molecular basis of transcriptional regulation by determining whether there are specific IFN-responsive elements in the 5' region upstream from the start site of the EGF receptor gene. This will be done using cloned segments of this gene and transient expression assays. We will also determine whether there are transcription factors that bind such elements.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM036716-08
Application #
2178497
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1991-07-01
Project End
1995-06-30
Budget Start
1993-07-01
Budget End
1995-06-30
Support Year
8
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Tennessee Health Science Center
Department
Pathology
Type
Schools of Medicine
DUNS #
941884009
City
Memphis
State
TN
Country
United States
Zip Code
38163
Yang, C H; Shi, W; Basu, L et al. (1996) Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor. J Biol Chem 271:8057-61
Pfeffer, L M; Wang, C; Constantinescu, S N et al. (1996) Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions. J Urol 156:1867-71
Mullersman, J E; Pfeffer, L M (1995) A novel cytoplasmic homology domain in interferon receptors. Trends Biochem Sci 20:55-6
Constantinescu, S N; Croze, E; Murti, A et al. (1995) Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex. Proc Natl Acad Sci U S A 92:10487-91
Constantinescu, S N; Croze, E; Wang, C et al. (1994) Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex. Proc Natl Acad Sci U S A 91:9602-6
Tamm, I; Kikuchi, T; Kreutter, D et al. (1994) Selective interferon-alpha/beta effects on platelet-derived growth factor-stimulated processes in quiescent BALB/c-3T3 fibroblasts. J Interferon Res 14:265-73
Colamonici, O R; Domanski, P; Krolewski, J J et al. (1994) Interferon alpha (IFN alpha) signaling in cells expressing the variant form of the type I IFN receptor. J Biol Chem 269:5660-5
Colamonici, O R; Porterfield, B; Domanski, P et al. (1994) Complementation of the interferon alpha response in resistant cells by expression of the cloned subunit of the interferon alpha receptor. A central role of this subunit in interferon alpha signaling. J Biol Chem 269:9598-602
Wang, C; Constantinescu, S N; MacEwan, D J et al. (1993) Interferon alpha induces protein kinase C-epsilon (PKC-epsilon) gene expression and a 4.7-kb PKC-epsilon-related transcript. Proc Natl Acad Sci U S A 90:6944-8
Improta, T; Pine, R; Pfeffer, L M (1992) Interferon-gamma potentiates the antiviral activity and the expression of interferon-stimulated genes induced by interferon-alpha in U937 cells. J Interferon Res 12:87-94

Showing the most recent 10 out of 29 publications